Comparison of Antiphospholipid Antibody Levels in Children with and Without COVID-19
Archives of Pediatric Infectious Diseases · 2023
DOI: 10.5812/apid-133851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Pediatric Infectious Diseases, 2023. Verfasst von Salimeh Noorbakhsh und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the recent pandemic. According to published reports, respiratory symptoms, such as pneumonia and inflammatory conditions, are common in this disease.
Objectives
The current study aimed to investigate the level of antiphospholipid (aPL) antibodies in children with and without coronavirus disease 2019 (COVID-19).
Methods
This descriptive-analytic cross-sectional study was conducted on patients under 16 years of age with and without COVID-19 admitted to Ali Asghar Hospital between December 2021 and February 2022. Patient information was collected by the researcher in a checklist. The checklist included demographic information, clinical findings, and information on laboratory and ultrasound results.
Results
In this study, 99 patients were evaluated in three groups: control (without COVID-19), moderate, and severe. The means (standard deviation [SD]) of C-reactive protein (CRP) and D-dimer were significantly higher in the severe group. The Pearson correlation coefficient test was used to examine the relationship between aPL and anticardiolipin (aCL) antibodies with laboratory results. The only significant and direct relationship was observed between aCL antibody and D-dimer.
Conclusions
Increased CRP and D-dimer in children with COVID-19 are associated with the severe form of this serious disease. However, there was no significant association between the severity of the disease and the levels of aCL and aPL antibodies and anti-beta 2-glycoprotein I antibodies (aβ2GPI) in children.
Zitieren
APA
Noorbakhsh, S., Ehsanipour, F., Sobouti, B., Aski, B. H., Faranoush, M., Mousavi, A., Ghadipasha, A., & Sadr, Z. (2023). Comparison of Antiphospholipid Antibody Levels in Children with and Without COVID-19. Archives of Pediatric Infectious Diseases. https://doi.org/10.5812/apid-133851
Vancouver
Noorbakhsh S, Ehsanipour F, Sobouti B, Aski BH, Faranoush M, Mousavi A, et al. Comparison of Antiphospholipid Antibody Levels in Children with and Without COVID-19. Archives of Pediatric Infectious Diseases. 2023. doi:10.5812/apid-133851
BibTeX
@article{Noorbakhsh2023,
author = {Noorbakhsh, Salimeh and Ehsanipour, Fahimeh and Sobouti, Behnam and Aski, Behzad Haghighi and Faranoush, Mohammad and Mousavi, Ashraf and Ghadipasha, Amir and Sadr, Zahra},
title = {Comparison of Antiphospholipid Antibody Levels in Children with and Without COVID-19},
journal = {Archives of Pediatric Infectious Diseases},
year = {2023},
doi = {10.5812/apid-133851}
}
EUVIMED